Search

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

The timing couldn’t have been worse. As the European Commission announces two new public/private research partnerships, it admits that its flagship partnership project - the ambitious Galileo satellite system - has crashed and burned.

Portugal takes the EU helm on 1 July - and is planning new measures to revitalize the "Lisbon Agenda" for high-tech growth, says tech-policy leader Carlos Zorrinho.

Europe now has a European Space Policy to direct its research programmes and activities and avoid duplication of effort between member states. The policy was formally adopted at the Competitiveness Council meeting on Tuesday 22 May.

A new report describes the spread of the "global innovation network" model.

Soon it won’t be possible to fund the huge enterprises of the leading pharma companies with a handful of blockbuster drugs. The only question is whether they can change and innovate in time.

The development agency Scottish Enterprise is teaming up with one of the US’s leading life science property specialists to develop Edinburgh BioQuarter.

Don't fall in love with your technology, advises Dinko Valerio, a leading Dutch bio entrepreneur and VC.

When it comes to biotech, the public sector is forging ahead in terms of intellectual property outputs, but the lead taken by academic institutions is almost entirely limited to the US.

The German state of Rheinland-Pfalz has supported the opening of a new innovation cluster to carry out research and development in the commercial vehicle sector.

The Indian economy may be drawing nervous glances from Europe but its universities, famous for churning out 2.5 million graduates every year, are faltering.